An experimental gene-editing therapy that aims to lower bad cholesterol for the long-term after a single infusion is off to a ...
Pharmaceutical companies have spent years targeting a common blood particle associated with heart-attack risks.
A study published in the New England Journal of Medicine revealed a new therapy that can cut “bad” cholesterol by 62 percent ...
High cholesterol is one of the most common and manageable risk factors for heart disease. Millions of adults are prescribed cholesterol-lowering drugs to reduce low-density lipoprotein (LDL) ...
Newspoint on MSN
Bad cholesterol: The hassle of medicines will end; only gene therapy will provide a one-time treatment for bad cholesterol
LDL Reduction: Studies have found that this therapy successfully reduced LDL cholesterol by up to 62 percent. Let's explain ...
Patients in London have received a pioneering new gene editing therapy that lowers "bad" cholesterol after a single infusion, ...
If it continues to work in further studies, a gene therapy in development could eliminate the need for daily pills or regular ...
Novartis, Amgen and Eli Lilly are among the pharmaceutical companies developing drugs to lower levels of a particularly bad form of cholesterol called Lp(a) and potentially prevent heart attacks. Lp(a ...
An experimental gene-editing treatment shows promise for permanently lowering levels of cholesterol and triglycerides, possibly helping cut the... CRISPR gene-editing works to reduce high cholesterol ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results